Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Blind Procedures

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Disability Liaison Officers and emergency department diversion: a retrospective analysis from an Australian health service.

Australian journal of primary health·2026

Same author

Persistent health inequalities over 20 years among adults with intellectual disabilities who display behaviours that challenge: evidence from English primary care records.

BJPsych open·2026

Same author

Pharmacists' contribution to improving vaccination uptake among children: A systematic review.

Research in social & administrative pharmacy : RSAP·2026

Same author

Process evaluation of SPECTROM training: Staff views from a feasibility cluster RCT.

Journal of intellectual & developmental disability·2026

Same author

An Australian Co-Designed Template for Accessible Medicines Information for People With Intellectual Disability.

Journal of applied research in intellectual disabilities : JARID·2026

Same author

The Evidence Informing Hypoglycaemia Treatment Thresholds in Asymptomatic, Term, Well Newborns: A Review of Literature and Critical Appraisal of Methodological Challenges.

Journal of human lactation : official journal of International Lactation Consultant Association·2026

Search research articles

Related Experiment Video

Updated: Mar 6, 2026

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research

Published on: July 31, 2017

ASPIRE-Med project: a study protocol on an Australian psychotropic medicines training programme for disability

Macey Barratt^1,2, Kathryn Speer^3,2, Shoumitro Deb⁴

¹Centre for Ageing Research and Translation, University of Canberra, Bruce, Australian Capital Territory, Australia Macey.Barratt@canberra.edu.au.

|March 4, 2026

Summary

This project protocol outlines a training program for disability support workers (DSWs) on appropriate psychotropic medicine use in individuals with intellectual and developmental disabilities. The training aims to enhance DSWs

Keywords:

Community-Based Participatory Research Disabled Persons MENTAL HEALTH Medicine Person-Centered Care

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

Published on: July 31, 2016

Related Experiment Videos

Last Updated: Mar 6, 2026

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research

Published on: July 31, 2017

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

Published on: July 31, 2016

Area of Science:

Intellectual and Developmental Disabilities
Psychopharmacology
Healthcare Workforce Training

Background:

Overmedication of psychotropic medicines for behaviors of concern in individuals with intellectual and developmental disabilities (IDD) is a significant public health issue.
Disability Support Workers (DSWs) are crucial in managing psychotropic medication for adults with IDD.
There is a critical need for targeted DSW training on the appropriate use of these medications.

Purpose of the Study:

To develop a comprehensive training program for DSWs focused on the appropriate use of psychotropic medicines in individuals with IDD.
To improve DSWs' knowledge, confidence, and skills in managing psychotropic medications and supporting individuals with IDD.

Main Methods:

A participatory action framework and Universal Design for Learning approach will guide program development.
Co-production involving people with IDD, families, DSWs, healthcare professionals, and educational designers.
Key steps include needs analysis, literature review, focus groups, co-design events, field testing, a feasibility trial with a train-the-trainer model, and mixed-method process evaluation.

Main Results:

The training is expected to improve DSWs' knowledge of appropriate psychotropic prescribing for individuals with IDD.
Enhanced confidence in communication with healthcare professionals and application of non-pharmacological strategies.
Promotion of shared decision-making, advocacy for medication reviews, and positive interactions.

Conclusions:

The developed training program aims to equip DSWs with essential skills for appropriate psychotropic medicine management in IDD.
The program's co-production and dissemination across Australia, offered free to DSWs, ensures broad accessibility.
Successful implementation is anticipated to positively influence client outcomes and support practices for individuals with IDD.